60 Degrees Pharma Raises $1.0M in Private Placement
60 Degrees Pharmaceuticals, Inc. announced it has entered into definitive agreements for a private placement to issue and sell an aggregate of 574,713 shares of its common stock (or pre-funded warrants) along with Series A and short-term Series B warrants. The purchase price is $1.74 per share and accompanying warrants, with an exercise price of $1.49 per share for the warrants. The offering is expected to generate approximately $1.0 million in gross proceeds, which the company intends to use for working capital and general corporate purposes.
Key Highlights
- Entered definitive agreements for a private placement of common stock and warrants.
- Issuance of 574,713 shares of common stock (or pre-funded warrants).
- Issuance of Series A warrants to purchase up to 574,713 shares.
- Issuance of short-term Series B warrants to purchase up to 574,713 shares.
- Purchase price of $1.74 per share (or pre-funded warrant) and accompanying warrants.
- Warrants have an exercise price of $1.49 per share.
- Expected gross proceeds of approximately $1.0 million.
- Net proceeds to be used for working capital and general corporate purposes.
Price Impact
More from SXTP
60 Degrees Pharmaceuticals Plans January 2027 Babesiosis Data Readout
60 Degrees Pharma Reaches Babesiosis Trial Interim Analysis Milestone
60 Degrees Pharma Details Tafenoquine Babesiosis Trial Interim Analysis Plan